Related Experiment Video
Updated: Mar 21, 2026
05:23
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
20.6K
Adults with cyanotic congenital heart disease: hematologic management
J K Perloff1, M H Rosove, J S Child
1UCLA Center for the Health Sciences.
Annals of Internal Medicine
|September 1, 1988
Summary
Managing cyanotic adults with congenital heart disease requires attention to erythrocyte mass and oxygen transport. Guidelines focus on symptomatic hyperviscosity, iron deficiency, and renal function, not routine phlebotomy or antithrombotics.
Area of Science:
- Cardiology
- Hematology
- Internal Medicine
Background:
- Cyanotic congenital heart disease (CCHD) affects adults, yet practical hematologic management guidelines are scarce.
- Adults with CCHD present unique hematologic challenges requiring specialized care.
- Current understanding of hematologic issues in adult CCHD is limited, necessitating updated guidance.
Purpose of the Study:
- To provide practical therapeutic guidelines for the hematologic management of adults with CCHD.
- To consolidate observations on 124 adult patients with CCHD.
- To inform general physicians, cardiologists, and hematologists on managing CCHD-related hematologic complications.
Main Methods:
- Review of clinical observations from 124 adult patients with CCHD.
- Analysis of erythrocyte mass regulation, erythrocytosis, tissue oxygen transport, and hyperviscosity.
- Evaluation of iron deficiency, hemostasis, urate metabolism, and renal function in CCHD patients.
Main Results:
- Cerebral infarction was not observed in any patient.
- Phlebotomy is recommended only for symptomatic hyperviscosity.
- Iron therapy is indicated for symptomatic iron-deficient erythropoiesis.
- Abnormal hemostasis is common; antithrombotic medications have limited utility.
- Hyperuricemia is linked to renal uric acid excretion, not overproduction, and indicates renal dysfunction.
Conclusions:
- Hematologic management of adult CCHD should focus on addressing symptomatic complications rather than routine interventions.
- Phlebotomy should be reserved for symptomatic hyperviscosity, and iron therapy for iron deficiency.
- Hyperuricemia in CCHD patients serves as a marker for renal dysfunction, managed by promoting urate excretion.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
643
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
643
01:29Cardiomyopathy VI: Nursing Management
444
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
444
01:29Cardiomyopathy V: Interprofessional Care
605
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
605
01:30Heart Failure V: Medical Management
506
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
506
01:20Rheumatic Heart Disease IV: Nursing Management
437
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
437
01:21Rheumatic Heart Disease III: Medical Management
480
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
480